Phase 3 Crohn Disease Clinical Trials
5 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–5 of 5 trials
Recruiting
Phase 2Phase 3
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Crohn Disease
Janssen Research & Development, LLC1,092 enrolled324 locationsNCT07196722
Recruiting
Phase 3
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Crohn DiseaseColitis Ulcerative
Merck Sharp & Dohme LLC1,380 enrolled37 locationsNCT06651281
Recruiting
Phase 3
Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal
Crohn Disease
Assistance Publique - Hôpitaux de Paris150 enrolled1 locationNCT04997733
Recruiting
Phase 3
Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
Crohn DiseaseMethotrexateAzathioprine
Centre Hospitalier Universitaire, Amiens166 enrolled1 locationNCT05040464
Recruiting
Phase 2Phase 3
Precise Infliximab Exposure and Pharmacodynamic Control
Crohn Disease
Children's Hospital Medical Center, Cincinnati180 enrolled11 locationsNCT05660746